Company / Total Debt
Twist Bioscience Corp Total Debt History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$1.4M
FY2020
5-year range
-
FY2018-FY2020
Trend
-68.1%
vs FY2019
Sector context
#83 of 86
Health Care
What the data says
Among 86 Health Care companies, Twist Bioscience Corp is in the top 3% for total debt. Improved from $7M to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2020.
Improved from $7M to $1M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 86This company $1.4M Sector average $6.0B
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2020, total debt decreased 68.1% year-over-year.
- Ranks #83 out of 86 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $1.4M | -68.1% |
| FY2019 | $4.4M | -39.0% |
| FY2018 | $7.2M | - |
| FY2017 | - | - |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026